Potassium Citrate Sustained Release Tablets

The main ingredient of this product is potassium citrate.

This product is used for renal tubular acidosis with calcium stones, hypocitraturic calcium oxalate kidney stones caused by any cause, and uric acid stones with or without calcium stones.

1. Patients with hyperkalemia are prohibited from using this product (or patients with diseases or factors that can cause hyperkalemia; 2. Patients with diseases that delay or prevent the tablets from passing through the digestive tract are prohibited from using this product; 3. Patients with digestive tract ulcers are prohibited from using this product; 4. Patients with active urinary tract infection are prohibited from using this product (accompanied by urea-decomposing bacteria or other bacteria that are associated with calcium stones or struvite stones); 5. Patients with renal insufficiency are prohibited from using this product (glomerular filtration rate is less than 0.7 ml/kg/min); 6. Pregnant and lactating women should use this product with caution.

Precautions during pregnancy and lactation: Use with caution in pregnant and lactating women.

1.08g

Livzon (GROUP) Pharmaceutical FACTORY

• Founded in:

  1989-11-26

• Address:

  No. 38 Chuangye North Road, Jinwan District, Zhuhai City

• Tax NO.:

  91440400617489061P

• Registered Funds:

  450 million yuan

• Website:

  Log in to view

• Email:

  Log in to view